Mohamad Hasan Jawadi

Mohamad Hasan Jawadi

Auto-generated profile, based on publicly available information

Mohamad Hasan Jawadi

Department of Internal Medicine Wayne State University Detroit Michigan USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2026 in Annals of Noninvasive Electrocardiology
Verified
Journal Article
Open access
PDF file
MCMedhat Chowdhury
Medhat Chowdhury
SDSanchit Duhan
Sanchit Duhan
ABAbdul Rasheed Bahar
Abdul Rasheed Bahar
MJMohamad Hasan Jawadi
Mohamad Hasan Jawadi
BKBijeta Keisham
Bijeta Keisham
MZMarcel Zughaib
Marcel Zughaib
Background: Ventricular tachycardia (VT) is a major cause of morbidity and mortality in patients with structural heart disease, yet real‐world comparisons between ischemic cardiomyopathy (ICM) and non‐ischemic dilated cardiomyopathy (NIDCM) remain limited. Methods: The national readmission database (2016–2020) was used to identify hospitalizations for VT. Cohorts were stratified based on underlying cardiomyopathy. A Propensity Score Matching (PSM) model matched ICM to NIDCM patients. Pearson's x2 test was applied to PSM‐matched cohorts to compare outcomes. Results: We identified 622,092 VT hospitalizations, of which 575,312 (92.4%) had ICM and 46,780 (7.5%) had NIDCM. Outcomes were compared using multivariable logistic regression and propensity score matching (25,919 matched pairs). Despite being younger, NIDCM patients had higher in‐hospital mortality (10.4% vs. 9.6%, p < 0.001; aOR 1.08), stroke (1.7% vs. 1.2%, aOR1.42), acute heart failure (65% vs. 59%, aOR 1.36), acute kidney injury (46.1% vs. 41.7%, aOR1.35), endotracheal intubation (13.1% vs. 14.5%, aOR 1.06), ICD implantation (3.9% vs. 3.5%, aOR1.23), and VT ablation (1.0% vs. 0.5%, aOR1.76). Readmission rates were significantly higher in NIDCM at 30 days (10.4% vs. 8.7%, p = 0.019), 90 days (22.7% vs. 20.0%, p = 0.483), and 180 days (30.7% vs. 27.3%, p = 0.001). In contrast, ICM patients had higher rates of sudden cardiac arrest (10.6% vs. 5.9%, aOR0.55), major adverse cardiovascular events (78.9% vs. 52.2%, aOR0.24), cardiogenic shock (18.4% vs. 12.1%, aOR0.59), ECMO (0.9% vs. 0.4%, aOR0.48), and LVAD use (0.5% vs. 0.3%, aOR0.58). Mortality declined over time in ICM (8.5% in 2016 to 8.2% in 2020, p ‐trend = 0.006), but not in NIDCM. Conclusion: These findings highlight distinct clinical profiles and emphasize the need for targeted management strategies for VT based on the cardiomyopathy subtype.

11 December 2025 in Journal of the Society for Cardiovascular Angiography & Interventions
Verified
Journal Article
Open access
ABAbdul Rasheed Bahar
Abdul Rasheed Bahar
IKIshaq Khoury
Ishaq Khoury
MHMohammad Hamza
Mohammad Hamza
SJSultana Jahan
Sultana Jahan
MJMohamad Hasan Jawadi
Mohamad Hasan Jawadi
MAM. Chadi Alraies
M. Chadi Alraies
Left atrial appendage occlusion (LAAO) has emerged as a promising adjunctive strategy for stroke prevention in patients with atrial fibrillation (AF) undergoing cardiac surgery. While previous studies have assessed its efficacy, a comprehensive evaluation integrating both randomized controlled trials and observational data remains limited. We conducted a systematic review and meta-analysis to evaluate the safety and effectiveness of LAAO compared with no LAAO in patients with AF undergoing cardiac surgery. A total of 20 studies (12 observational and 8 randomized controlled trials) encompassing 215,181 patients treated between 2005 and 2024 were included. Pooled odds ratios with 95% CIs were calculated using fixed- and random-effects models for primary and secondary outcomes, with heterogeneity, publication bias, and sensitivity analyses performed in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Left atrial appendage occlusion was associated with a significant reduction in ischemic stroke (odds ratio, 0.72; 95% CI, 0.66-0.79), systemic embolism, hemorrhagic stroke, silent cerebral infarcts, and cardiac death. A significant reduction in all-cause mortality was observed using a fixed-effects model, but not with the random-effects model due to substantial heterogeneity. No significant differences were observed in myocardial infarction, peripheral ischemia, or major bleeding events. Sensitivity and cumulative analyses supported the robustness of the ischemic stroke findings. Subgroup analyses revealed no significant variation in outcomes based on study design or publication year. Left atrial appendage occlusion during cardiac surgery is associated with a significant reduction in thromboembolic events, without increasing the risk of major complications. These findings support the role of LAAO as a safe and effective adjunctive intervention in appropriately selected patients with AF. Further high-quality, prospective studies are warranted to confirm these benefits and inform guideline-directed practice.